Akorn Pharmaceuticals

Akorn Investor Relations

Akorn, Inc. at Jefferies 2019 Global Healthcare Conference

06/07/19 9:30 AM EDT

Disclosure Note: This webcast may include forward-looking statements about, among other things, Akorn’s business plans and initiatives, Akorn’s commitments to the FDA and remediation efforts, disruptions during the Standstill Period, Akorn’s anticipated future operating and financial performance, business plans and prospects, product pipeline, including filings, approvals and launches, capital allocation, debt refinancing, and potential dispositions, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Akorn’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018, and its subsequent reports on Form 10-Q, including the sections thereof captioned “Risk Factors” as well as in its subsequent reports on Form 8-K , all of which are filed with the U.S Securities and Exchange Commission and available at www.sec.gov and www.akorn.com. Readers should carefully review these risk factors, and should not place undue reliance on the company’s forward-looking statements. The forward-looking statements in the webcast speak only as of the original date of the webcast. Akorn assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.